Latest Breaking News On - Next oncology - Page 1 : comparemela.com

Valerio Therapeutics Reports Full Year 2023 Financial Results and Provides Clinical Development Updates

30.04.2024 - Regulatory News: Valerio Therapeutics S.A. (Euronext Growth Paris: ALVIO), hereafter “Valerio Therapeutics” or the “Company”), a clinical-stage biotechnology company specializing in the development of innovative drugs targeting tumor DNA Damage .

San antonioUnited statesRobert colemanNicolas treboutaAmerican association for cancer researchCompany groupNext oncologyValerio therapeuticsTargeting multiple proteinsRepair pathwaysInhibiting differentAmerican associationCancer researchInvestigational new drugAnnual general meetingEuronext growth paris

Valerio Therapeutics S A : Valerio Therapeutics Reports Full Year 2023 Financial Results and Provides Clinical Development Updates

Valerio Therapeutics S A : Valerio Therapeutics Reports Full Year 2023 Financial Results and Provides Clinical Development Updates
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesSan antonioRobert colemanNicolas treboutaShefali agarwalAmerican association for cancer researchCompany groupEuronext growth parisValerio therapeuticNext oncologyValerio therapeuticsTargeting multiple proteins repair pathwaysInhibiting differentAmerican associationCancer researchInvestigational new drug

Valerio Therapeutics Reports Full Year 2023 Financial Results and Provides Clinical Development Updates

Cash position of €6.8 million as of December 31, 2023 Financial visibility until the end of fourth quarter of 2024 .

United statesSan antonioShefali agarwalNicolas treboutaRobert colemanAmerican association for cancer researchCompany groupRegulatory newsEuronext growth parisValerio therapeuticNext oncologyValerio therapeuticsTargeting multiple proteinsRepair pathwaysInhibiting differentAmerican association

Erasca Announces Three Presentations at the 2024 ASCO Annual Meeting

Erasca Announces Three Presentations at the 2024 ASCO Annual Meeting
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesMccormick placeJoyce allaireAparna parikhAlex spiraMccormick place convention centerExchange commissionErasca incAmerican society of clinical oncologyLifesci advisorsMemorial sloan kettering cancer centerAnnounces three presentationsAmerican societyClinical oncologyAnnual meetingRapid oral

D2M Biotherapeutics Announces First Patient Dosed In A Phase 1 Study Evaluating

D2M Biotherapeutics Announces First Patient Dosed In A Phase 1 Study Evaluating
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesNan bingM biotherapeutics incTreating patientsAdvanced solid tumorsPrincipal investigatorShiraj senNext oncologyB specific iggTarget identification